Gilead Sciences is investing an additional $11 billion into its U.S. operations, the company announced this week, bringing its total investments in U.S. manufacturing and R&D through 2030 to more than $32 billion. “Our U.S. R&D and manufacturing investments in the U.S. will create $43 billion in value to the U.S. economy over the next five years through direct capital investment and job creation,” the company stated. This investment further bolsters Gilead’s domestic research, deve...